For the latest
cancer COVID-19 resources, click on this link
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Brain & nervous system
Sign up for latest coverage
Submit your event
cancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Prevention & screening
Middle East and North Africa
Central America and the Caribbean
Australia and Oceania
7 - 10 Dec 2019
Orlando, Orlando, United States of America
ASH 2019: New drug markedly improves overall survival in patients with AML in remission
ASH 2019: Study reveals genetic underpinnings of AML and myelodysplastic syndrome
ASH 2019: Triple drug combination delays disease progression in people with stubborn multiple myelom...
ASH 2019: Immunotherapy superior to chemotherapy for children with relapsed B-ALL
ASH 2019: Combination therapy aimed at slowing the progression of a precursor myeloma condition
ASH 2019: Novel immunotherapy agent for multiple myeloma shows promising pre-clinical results
ASH 2019: Treatment with PD-1 inhibitor prior to stem cell transplant is safe, effective for patient...
ASH 2019: CAR-T immunotherapy shows success and reduces health care utilisation in older patients
ASH 2019: Genomic features of AML in patients over age 60 can predict success of bone marrow stem ce...
ASH 2019: Dual-targeted antibody elicits durable responses in poor-prognosis non-Hodgkin Lymphoma
ASH 2019: Novel off-the-shelf CAR NK product overcomes CD19 antigen escape in preclinical studies
ASH 2019: High response rate seen with BCMA-directed CAR T-cell therapy for multiple myeloma
ASH 2019: Encouraging results for dual-targeted CAR T-cell therapy in hard-to-treat multiple myeloma